{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:23:39Z","timestamp":1792157019679,"version":"4.4.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100015226","name":"Shengjing Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-025-01906-z","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T15:49:01Z","timestamp":1749224941000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["DNA methylation in monozygotic twins discordant for acute lymphoblastic leukemia: a case report and systematic review"],"prefix":"10.1186","volume":"17","author":[{"given":"Mao-ling","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-xi","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-qing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"issue":"1","key":"1906_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1906_CR2","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.biopha.2017.11.033","volume":"97","author":"M Rahmani","year":"2018","unstructured":"Rahmani M, et al. Aberrant DNA methylation of key genes and Acute Lymphoblastic Leukemia. Biomed Pharmacother. 2018;97:1493\u2013500.","journal-title":"Biomed Pharmacother"},{"issue":"46","key":"1906_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005300","volume":"95","author":"SK Singh","year":"2016","unstructured":"Singh SK, et al. A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants. Medicine (Baltimore). 2016;95(46): e5300.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1906_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41375-022-01756-1","volume":"37","author":"AM Ford","year":"2023","unstructured":"Ford AM, Colman S, Greaves M. Covert pre-leukaemic clones in healthy co-twins of patients with childhood acute lymphoblastic leukaemia. Leukemia. 2023;37(1):47\u201352.","journal-title":"Leukemia"},{"issue":"1","key":"1906_CR5","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1038\/s41467-022-33677-z","volume":"13","author":"EM Nickels","year":"2022","unstructured":"Nickels EM, et al. DNA methylation at birth in monozygotic twins discordant for pediatric acute lymphoblastic leukemia. Nat Commun. 2022;13(1):6077.","journal-title":"Nat Commun"},{"key":"1906_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-981-10-3233-2_14","volume":"962","author":"AM Ford","year":"2017","unstructured":"Ford AM, Greaves M. ETV6-RUNX1 (+) acute lymphoblastic leukaemia in identical twins. Adv Exp Med Biol. 2017;962:217\u201328.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"1906_CR7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2217\/epi-2015-0011","volume":"8","author":"JA Timms","year":"2016","unstructured":"Timms JA, et al. DNA methylation as a potential mediator of environmental risks in the development of childhood acute lymphoblastic leukemia. Epigenomics. 2016;8(4):519\u201336.","journal-title":"Epigenomics"},{"issue":"1","key":"1906_CR8","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1038\/s41598-020-58123-2","volume":"10","author":"R Sanchez","year":"2020","unstructured":"Sanchez R, Mackenzie SA. Integrative network analysis of differentially methylated and expressed genes for biomarker identification in leukemia. Sci Rep. 2020;10(1):2123.","journal-title":"Sci Rep"},{"issue":"11","key":"1906_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187422","volume":"12","author":"R Chaber","year":"2017","unstructured":"Chaber R, et al. Whole-genome DNA methylation characteristics in pediatric precursor B cell acute lymphoblastic leukemia (BCP ALL). PLoS ONE. 2017;12(11): e0187422.","journal-title":"PLoS ONE"},{"key":"1906_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.semcancer.2017.09.001","volume":"51","author":"J Nordlund","year":"2018","unstructured":"Nordlund J, Syvanen AC. Epigenetics in pediatric acute lymphoblastic leukemia. Semin Cancer Biol. 2018;51:129\u201338.","journal-title":"Semin Cancer Biol"},{"key":"1906_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aat2624","author":"NJ Kessler","year":"2018","unstructured":"Kessler NJ, et al. Establishment of environmentally sensitive DNA methylation states in the very early human embryo. Sci Adv. 2018. https:\/\/doi.org\/10.1126\/sciadv.aat2624.","journal-title":"Sci Adv"},{"issue":"1","key":"1906_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13059-017-1374-0","volume":"19","author":"TE Van Baak","year":"2018","unstructured":"Van Baak TE, et al. Epigenetic supersimilarity of monozygotic twin pairs. Genome Biol. 2018;19(1):2.","journal-title":"Genome Biol"},{"issue":"8","key":"1906_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007544","volume":"14","author":"E Hannon","year":"2018","unstructured":"Hannon E, et al. Characterizing genetic and environmental influences on variable DNA methylation using monozygotic and dizygotic twins. PLoS Genet. 2018;14(8): e1007544.","journal-title":"PLoS Genet"},{"issue":"12","key":"1906_CR14","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1158\/0008-5472.CAN-15-3278","volume":"76","author":"M Klutstein","year":"2016","unstructured":"Klutstein M, et al. DNA methylation in cancer and aging. Cancer Res. 2016;76(12):3446\u201350.","journal-title":"Cancer Res"},{"issue":"6","key":"1906_CR15","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s43018-022-00370-5","volume":"3","author":"S Hetzel","year":"2022","unstructured":"Hetzel S, et al. Acute lymphoblastic leukemia displays a distinct highly methylated genome. Nat Cancer. 2022;3(6):768\u201382.","journal-title":"Nat Cancer"},{"issue":"8","key":"1906_CR16","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.4014\/jmb.1704.04035","volume":"27","author":"SJ Choi","year":"2017","unstructured":"Choi SJ, et al. Alteration of DNA methylation in gastric cancer with chemotherapy. J Microbiol Biotechnol. 2017;27(8):1367\u201378.","journal-title":"J Microbiol Biotechnol"},{"issue":"10","key":"1906_CR17","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1038\/leu.2017.12","volume":"31","author":"AD Kelly","year":"2017","unstructured":"Kelly AD, et al. A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome. Leukemia. 2017;31(10):2011\u20139.","journal-title":"Leukemia"},{"issue":"1","key":"1906_CR18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/16078454.2019.1642563","volume":"24","author":"LL Cao","year":"2019","unstructured":"Cao LL, et al. The clinical values of dysregulated DNA methylation and demethylation intermediates in acute lymphoblastic leukemia. Hematology. 2019;24(1):567\u201376.","journal-title":"Hematology"},{"issue":"3","key":"1906_CR19","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3390\/ijms22031388","volume":"22","author":"N Mackowska","year":"2021","unstructured":"Mackowska N, et al. DNA methylation in T-cell acute lymphoblastic leukemia: in search for clinical and biological meaning. Int J Mol Sci. 2021;22(3):1388.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1906_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/bjh.15449","volume":"182","author":"M Paganin","year":"2018","unstructured":"Paganin M, et al. The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols. Br J Haematol. 2018;182(5):705\u201311.","journal-title":"Br J Haematol"},{"issue":"4","key":"1906_CR21","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.bbrc.2020.02.021","volume":"524","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Lee S, Xu W. Miltefosine suppression of Pten null T-ALL leukemia via beta-catenin degradation through inhibition of pT308-Akt and TGFbeta1\/Smad3. Biochem Biophys Res Commun. 2020;524(4):1018\u201324.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3\u20134","key":"1906_CR22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000456572","volume":"150","author":"Z Ou","year":"2016","unstructured":"Ou Z, et al. The genomic landscape of PAX5, IKZF1, and CDKN2A\/B alterations in B-Cell precursor acute lymphoblastic leukemia. Cytogenet Genome Res. 2016;150(3\u20134):242\u201352.","journal-title":"Cytogenet Genome Res"},{"key":"1906_CR23","doi-asserted-by":"publisher","first-page":"10447","DOI":"10.3389\/ebm.2025.10447","volume":"250","author":"Y Wang","year":"2025","unstructured":"Wang Y, et al. Clinical characteristics and prognosis of ALL in children with CDKN2A\/B gene deletion. Exp Biol Med (Maywood). 2025;250:10447.","journal-title":"Exp Biol Med (Maywood)"},{"key":"1906_CR24","doi-asserted-by":"publisher","first-page":"1023606","DOI":"10.3389\/fonc.2022.1023606","volume":"12","author":"Z Jia","year":"2022","unstructured":"Jia Z, Gu Z. PAX5 alterations in B-cell acute lymphoblastic leukemia. Front Oncol. 2022;12:1023606.","journal-title":"Front Oncol"},{"issue":"5","key":"1906_CR25","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nbt.3423","volume":"34","author":"D Deamer","year":"2016","unstructured":"Deamer D, Akeson M, Branton D. Three decades of nanopore sequencing. Nat Biotechnol. 2016;34(5):518\u201324.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"1906_CR26","first-page":"1256","volume":"19","author":"A Magi","year":"2018","unstructured":"Magi A, et al. Nanopore sequencing data analysis: state of the art, applications and challenges. Brief Bioinform. 2018;19(6):1256\u201372.","journal-title":"Brief Bioinform"},{"issue":"1","key":"1906_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13059-016-1103-0","volume":"17","author":"M Jain","year":"2016","unstructured":"Jain M, et al. The Oxford Nanopore MinION: delivery of nanopore sequencing to the genomics community. Genome Biol. 2016;17(1):239.","journal-title":"Genome Biol"},{"issue":"1","key":"1906_CR28","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1038\/s41598-018-21484-w","volume":"8","author":"R Krishnakumar","year":"2018","unstructured":"Krishnakumar R, et al. Systematic and stochastic influences on the performance of the MinION nanopore sequencer across a range of nucleotide bias. Sci Rep. 2018;8(1):3159.","journal-title":"Sci Rep"},{"issue":"1","key":"1906_CR29","doi-asserted-by":"publisher","first-page":"7939","DOI":"10.1038\/s41467-022-35650-2","volume":"13","author":"X Yue","year":"2022","unstructured":"Yue X, et al. Simultaneous profiling of histone modifications and DNA methylation via nanopore sequencing. Nat Commun. 2022;13(1):7939.","journal-title":"Nat Commun"},{"issue":"4","key":"1906_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nmeth.4184","volume":"14","author":"JT Simpson","year":"2017","unstructured":"Simpson JT, et al. Detecting DNA cytosine methylation using nanopore sequencing. Nat Methods. 2017;14(4):407\u201310.","journal-title":"Nat Methods"},{"key":"1906_CR31","doi-asserted-by":"crossref","unstructured":"Stoiber M, et al. De novo identification of DNA modifications enabled by genome-guided nanopore signal processing. bioRxiv; 2017. 2016;94672.","DOI":"10.1101\/094672"},{"key":"1906_CR32","doi-asserted-by":"crossref","unstructured":"Tarailo-Graovac, M., Chen, N. Using RepeatMasker to identify repetitive elements in genomic sequences. Curr Protoc Bioinform; 2009. Chapter 4: 4 10 1\u20134 10 14","DOI":"10.1002\/0471250953.bi0410s25"},{"issue":"1","key":"1906_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/nar\/gkv1332","volume":"44","author":"H Liu","year":"2016","unstructured":"Liu H, et al. Systematic identification and annotation of human methylation marks based on bisulfite sequencing methylomes reveals distinct roles of cell type-specific hypomethylation in the regulation of cell identity genes. Nucleic Acids Res. 2016;44(1):75\u201394.","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"1906_CR34","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu G, Wang LG, He QY. ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics. 2015;31(14):2382\u20133.","journal-title":"Bioinformatics"},{"issue":"5","key":"1906_CR35","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"3","key":"1906_CR36","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s12253-016-0139-5","volume":"23","author":"Z Gaal","year":"2017","unstructured":"Gaal Z, et al. Strong correlation between the expression levels of HDAC4 and SIRT6 in hematological malignancies of the adults. Pathol Oncol Res. 2017;23(3):493\u2013504.","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"1906_CR37","doi-asserted-by":"publisher","first-page":"8730","DOI":"10.1038\/s41598-024-59443-3","volume":"14","author":"Y Liu","year":"2024","unstructured":"Liu Y, et al. Circular ZDHHC11 supports Burkitt lymphoma growth independent of its miR-150 binding capacity. Sci Rep. 2024;14(1):8730.","journal-title":"Sci Rep"},{"key":"1906_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.950326","volume":"13","author":"L Li","year":"2022","unstructured":"Li L, et al. Oncogene or tumor suppressor gene: an integrated pan-cancer analysis of NBPF1. Front Endocrinol (Lausanne). 2022;13: 950326.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1906_CR39","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12935-021-01966-0","volume":"21","author":"L Li","year":"2021","unstructured":"Li L, Zhao W. The mutual regulatory loop between TPTEP1 and miR-1303 in leukemogenesis of acute myeloid leukemia. Cancer Cell Int. 2021;21(1):260.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"1906_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cellsig.2013.09.021","volume":"26","author":"EC Hales","year":"2014","unstructured":"Hales EC, Taub JW, Matherly LH. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of gamma-secretase inhibitor resistant T-cell acute lymphoblastic leukemia. Cell Signal. 2014;26(1):149\u201361.","journal-title":"Cell Signal"},{"issue":"6\u20137","key":"1906_CR41","doi-asserted-by":"publisher","first-page":"e2898","DOI":"10.1002\/jgm.2898","volume":"19","author":"J Jin","year":"2017","unstructured":"Jin J, et al. MicroRNA-144 regulates cancer cell proliferation and cell-cycle transition in acute lymphoblastic leukemia through the interaction of FMN2. J Gene Med. 2017;19(6\u20137):e2898.","journal-title":"J Gene Med"},{"key":"1906_CR42","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20190040","author":"C Liu","year":"2019","unstructured":"Liu C, et al. USP39 regulates the cell cycle, survival, and growth of human leukemia cells. 2019. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20190040."},{"issue":"1","key":"1906_CR43","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1182\/blood-2014-07-591529","volume":"125","author":"VP Lavallee","year":"2015","unstructured":"Lavallee VP, et al. EVI1-rearranged acute myeloid leukemias are characterized by distinct molecular alterations. Blood. 2015;125(1):140\u20133.","journal-title":"Blood"},{"issue":"10","key":"1906_CR44","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/ajh.20690","volume":"81","author":"D Mahadevan","year":"2006","unstructured":"Mahadevan D, et al. Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia. Am J Hematol. 2006;81(10):779\u201386.","journal-title":"Am J Hematol"},{"key":"1906_CR45","doi-asserted-by":"publisher","first-page":"1116660","DOI":"10.3389\/fmolb.2023.1116660","volume":"10","author":"E Cuttini","year":"2023","unstructured":"Cuttini E, et al. HDAC4 in cancer: a multitasking platform to drive not only epigenetic modifications. Front Mol Biosci. 2023;10:1116660.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"1906_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-022-01221-6","volume":"8","author":"Z Hu","year":"2023","unstructured":"Hu Z, et al. Histone deacetylase inhibitors promote breast cancer metastasis by elevating NEDD9 expression. Signal Transduct Target Ther. 2023;8(1):11.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"1906_CR47","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/15548627.2019.1635380","volume":"16","author":"H Wu","year":"2020","unstructured":"Wu H, et al. MIR145-3p promotes autophagy and enhances bortezomib sensitivity in multiple myeloma by targeting HDAC4. Autophagy. 2020;16(4):683\u201397.","journal-title":"Autophagy"},{"issue":"2","key":"1906_CR48","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3892\/or.2012.1825","volume":"28","author":"T Qiu","year":"2012","unstructured":"Qiu T, et al. Rap1GAP alters leukemia cell differentiation, apoptosis and invasion in vitro. Oncol Rep. 2012;28(2):622\u20138.","journal-title":"Oncol Rep"},{"issue":"5","key":"1906_CR49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000516122","volume":"161","author":"B Faam","year":"2021","unstructured":"Faam B, et al. RAP1GAP functions as a tumor suppressor gene and is regulated by DNA methylation in differentiated thyroid cancer. Cytogenet Genome Res. 2021;161(5):227\u201335.","journal-title":"Cytogenet Genome Res"},{"key":"1906_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-5","author":"H Shi","year":"2020","unstructured":"Shi H, Xu B, Yang M. NF-kappaB signaling pathway promotes proliferation and inhibits apoptosis of childhood acute lymphoblastic leukemia cells via regulating CRIM1. Minerva Med. 2020. https:\/\/doi.org\/10.1186\/1476-4598-13-5.","journal-title":"Minerva Med"},{"key":"1906_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.882328","volume":"12","author":"W Wen","year":"2022","unstructured":"Wen W, et al. Low CRIM1 levels predict poor prognosis in breast cancer patients. Front Oncol. 2022;12: 882328.","journal-title":"Front Oncol"},{"key":"1906_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.656042","volume":"12","author":"W Wang","year":"2021","unstructured":"Wang W, et al. Identification of potential signatures and their functions for acute lymphoblastic leukemia: a study based on the cancer genome atlas. Front Genet. 2021;12: 656042.","journal-title":"Front Genet"},{"issue":"1","key":"1906_CR53","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13048-021-00830-z","volume":"14","author":"X Chang","year":"2021","unstructured":"Chang X, Dong Y. CACNA1C is a prognostic predictor for patients with ovarian cancer. J Ovarian Res. 2021;14(1):88.","journal-title":"J Ovarian Res"},{"issue":"10","key":"1906_CR54","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.7150\/ijbs.70866","volume":"18","author":"Y Shi","year":"2022","unstructured":"Shi Y, et al. Interaction between BEND5 and RBPJ suppresses breast cancer growth and metastasis via inhibiting Notch signaling. Int J Biol Sci. 2022;18(10):4233\u201344.","journal-title":"Int J Biol Sci"},{"issue":"22","key":"1906_CR55","doi-asserted-by":"publisher","first-page":"10575","DOI":"10.1111\/jcmm.16989","volume":"25","author":"M Liu","year":"2021","unstructured":"Liu M, et al. Colon cancer cells secreted CXCL11 via RBP-Jkappa to facilitated tumour-associated macrophage-induced cancer metastasis. J Cell Mol Med. 2021;25(22):10575\u201390.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"1906_CR56","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/leu.2014.281","volume":"29","author":"T Kato","year":"2015","unstructured":"Kato T, et al. Hes1 suppresses acute myeloid leukemia development through FLT3 repression. Leukemia. 2015;29(3):576\u201385.","journal-title":"Leukemia"},{"issue":"4","key":"1906_CR57","doi-asserted-by":"publisher","first-page":"e398","DOI":"10.1016\/j.clml.2020.11.012","volume":"21","author":"S Rana","year":"2021","unstructured":"Rana S, et al. 16q23\/MAF gene deletion is a frequent cytogenetic abnormality in multiple myeloma associated With IgH deletion but significantly lower incidence of high-risk translocations. Clin Lymphoma Myeloma Leuk. 2021;21(4):e398\u2013401.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"25","key":"1906_CR58","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1182\/blood-2016-03-706077","volume":"128","author":"YW Qiang","year":"2016","unstructured":"Qiang YW, et al. MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma. Blood. 2016;128(25):2919\u201330.","journal-title":"Blood"},{"key":"1906_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv256","author":"M Pavlovic","year":"2015","unstructured":"Pavlovic M, et al. Enhanced MAF oncogene expression and breast cancer bone metastasis. J Natl Cancer Inst. 2015. https:\/\/doi.org\/10.1093\/jnci\/djv256.","journal-title":"J Natl Cancer Inst"},{"key":"1906_CR60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.exphem.2023.07.001","volume":"125\u2013126","author":"Z Sun","year":"2023","unstructured":"Sun Z, et al. Critical role of MXRA7 in differentiation blockade in human acute promyelocytic leukemia cells. Exp Hematol. 2023;125\u2013126:45\u201354.","journal-title":"Exp Hematol"},{"issue":"11","key":"1906_CR61","first-page":"1182","volume":"10","author":"Z Iqbal","year":"2021","unstructured":"Iqbal Z, et al. Integrated Genomic analysis identifies ANKRD36 gene as a novel and common biomarker of disease progression in chronic myeloid Leukemia. Biology (Basel). 2021;10(11):1182.","journal-title":"Biology (Basel)"},{"issue":"2","key":"1906_CR62","first-page":"311","volume":"29","author":"M Absar","year":"2022","unstructured":"Absar M, et al. Clinical validation of Ankrd36 mutations as a novel biomarker for monitoring early progression and timely clinical interventions in blast crisis CML. J Popul Ther Clin Pharmacol. 2022;29(2):311\u201320.","journal-title":"J Popul Ther Clin Pharmacol"},{"issue":"1","key":"1906_CR63","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4161\/15592294.2014.988035","volume":"10","author":"L D'Amato","year":"2015","unstructured":"D\u2019Amato L, et al. ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias. Epigenetics. 2015;10(1):6\u201318.","journal-title":"Epigenetics"},{"issue":"18","key":"1906_CR64","doi-asserted-by":"publisher","first-page":"25836","DOI":"10.18632\/oncotarget.8283","volume":"7","author":"TH Liu","year":"2016","unstructured":"Liu TH, et al. The putative tumor activator ARHGEF3 promotes nasopharyngeal carcinoma cell pathogenesis by inhibiting cellular apoptosis. Oncotarget. 2016;7(18):25836\u201348.","journal-title":"Oncotarget"},{"issue":"2","key":"1906_CR65","doi-asserted-by":"publisher","first-page":"10723","DOI":"10.1080\/21655979.2021.2002499","volume":"12","author":"J Chen","year":"2021","unstructured":"Chen J, et al. RASA4 inhibits the HIFalpha signaling pathway to suppress proliferation of cervical cancer cells. Bioengineered. 2021;12(2):10723\u201333.","journal-title":"Bioengineered"},{"issue":"4","key":"1906_CR66","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/cancers11040558","volume":"11","author":"Y Wang","year":"2019","unstructured":"Wang Y, et al. TRPC3 regulates the proliferation and apoptosis resistance of triple negative breast cancer cells through the TRPC3\/RASA4\/MAPK pathway. Cancers (Basel). 2019;11(4):558.","journal-title":"Cancers (Basel)"},{"key":"1906_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.isci.2019.10.007","volume":"21","author":"L Li","year":"2019","unstructured":"Li L, et al. Tumor suppression of Ras GTPase-activating protein RASA5 through antagonizing Ras signaling perturbation in carcinomas. iScience. 2019;21:1\u201318.","journal-title":"iScience"},{"issue":"7","key":"1906_CR68","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1182\/blood-2010-12-323659","volume":"118","author":"D Roy","year":"2011","unstructured":"Roy D, et al. Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines. Blood. 2011;118(7):e32\u20139.","journal-title":"Blood"},{"issue":"9","key":"1906_CR69","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.4161\/epi.29941","volume":"9","author":"AR Poetsch","year":"2014","unstructured":"Poetsch AR, et al. RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia. Epigenetics. 2014;9(9):1252\u201360.","journal-title":"Epigenetics"},{"issue":"8","key":"1906_CR70","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1038\/s41375-019-0402-3","volume":"33","author":"NA McNeer","year":"2019","unstructured":"McNeer NA, et al. Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia. Leukemia. 2019;33(8):1934\u201343.","journal-title":"Leukemia"},{"key":"1906_CR71","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ebiom.2017.03.012","volume":"18","author":"H Lin","year":"2017","unstructured":"Lin H, et al. DHX32 promotes angiogenesis in colorectal cancer through augmenting beta-catenin signaling to induce expression of VEGFA. EBioMedicine. 2017;18:62\u201372.","journal-title":"EBioMedicine"},{"issue":"1","key":"1906_CR72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1756-9966-28-11","volume":"28","author":"C Huang","year":"2009","unstructured":"Huang C, et al. Up-regulation and clinical relevance of novel helicase homologue DHX32 in colorectal cancer. J Exp Clin Cancer Res. 2009;28(1):11.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1906_CR73","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/07853890.2021.1898674","volume":"53","author":"X Hu","year":"2021","unstructured":"Hu X, et al. DEAH-box polypeptide 32 promotes hepatocellular carcinoma progression via activating the beta-catenin pathway. Ann Med. 2021;53(1):437\u201347.","journal-title":"Ann Med"},{"key":"1906_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12038-019-9977-0","volume":"45","author":"D Pant","year":"2020","unstructured":"Pant D, et al. Hypoxia-induced changes in intragenic DNA methylation correlate with alternative splicing in breast cancer. J Biosci. 2020;45:1. https:\/\/doi.org\/10.1007\/s12038-019-9977-0.","journal-title":"J Biosci"},{"key":"1906_CR75","doi-asserted-by":"publisher","first-page":"9247","DOI":"10.1038\/srep09247","volume":"5","author":"H Lin","year":"2015","unstructured":"Lin H, et al. Overexpression of DHX32 contributes to the growth and metastasis of colorectal cancer. Sci Rep. 2015;5:9247.","journal-title":"Sci Rep"},{"issue":"6","key":"1906_CR76","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/leu.2017.94","volume":"31","author":"A Dzikiewicz-Krawczyk","year":"2017","unstructured":"Dzikiewicz-Krawczyk A, et al. ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma. Leukemia. 2017;31(6):1470\u20133.","journal-title":"Leukemia"},{"key":"1906_CR77","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","volume":"85","author":"L Yu","year":"2022","unstructured":"Yu L, Wei J, Liu P. Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol. 2022;85:69\u201394.","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"1906_CR78","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1615\/JEnvironPatholToxicolOncol.2023045403","volume":"42","author":"FA Rizwi","year":"2023","unstructured":"Rizwi FA, et al. Janus Kinase-signal transducer and activator of transcription inhibitors for the treatment and management of cancer. J Environ Pathol Toxicol Oncol. 2023;42(4):15\u201329.","journal-title":"J Environ Pathol Toxicol Oncol"},{"issue":"1","key":"1906_CR79","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12943-023-01929-1","volume":"23","author":"D Liang","year":"2024","unstructured":"Liang D, et al. JAK\/STAT in leukemia: a clinical update. Mol Cancer. 2024;23(1):25.","journal-title":"Mol Cancer"},{"key":"1906_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/biology11010090","author":"G Kaur","year":"2022","unstructured":"Kaur G, et al. DNA methylation: a promising approach in management of Alzheimer\u2019s disease and other neurodegenerative disorders. Biology (Basel). 2022. https:\/\/doi.org\/10.3390\/biology11010090.","journal-title":"Biology (Basel)"},{"issue":"1","key":"1906_CR81","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41576-024-00760-8","volume":"26","author":"ZD Smith","year":"2025","unstructured":"Smith ZD, Hetzel S, Meissner A. DNA methylation in mammalian development and disease. Nat Rev Genet. 2025;26(1):7\u201330.","journal-title":"Nat Rev Genet"},{"issue":"1\u20134","key":"1906_CR82","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000530641","volume":"9","author":"VRG Alves","year":"2023","unstructured":"Alves VRG, et al. A systematic review of LINE-1 methylation profile in psychiatric disorders. Complex Psychiatry. 2023;9(1\u20134):119\u201329.","journal-title":"Complex Psychiatry"},{"issue":"6","key":"1906_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2020.09.018","volume":"433","author":"C Papin","year":"2021","unstructured":"Papin C, et al. CpG Islands shape the epigenome landscape. J Mol Biol. 2021;433(6): 166659.","journal-title":"J Mol Biol"},{"issue":"5","key":"1906_CR84","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1101\/gr.269233.120","volume":"31","author":"B Giacopelli","year":"2021","unstructured":"Giacopelli B, et al. DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia. Genome Res. 2021;31(5):747\u201361.","journal-title":"Genome Res"},{"issue":"18","key":"1906_CR85","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.3390\/ijms20184576","volume":"20","author":"X Yang","year":"2019","unstructured":"Yang X, Wong MPM, Ng RK. Aberrant DNA methylation in acute myeloid leukemia and its clinical implications. Int J Mol Sci. 2019;20(18):4576.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1906_CR86","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3390\/ijms24010633","volume":"24","author":"L Kalinkova","year":"2022","unstructured":"Kalinkova L, et al. Targeting DNA methylation in leukemia, myelodysplastic syndrome, and lymphoma: a potential diagnostic, prognostic, and therapeutic tool. Int J Mol Sci. 2022;24(1):633.","journal-title":"Int J Mol Sci"},{"issue":"22","key":"1906_CR87","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"WHO","year":"2013","unstructured":"WHO. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368(22):2059\u201374.","journal-title":"N Engl J Med"},{"issue":"1","key":"1906_CR88","doi-asserted-by":"publisher","first-page":"402","DOI":"10.2353\/ajpath.2010.090236","volume":"176","author":"H Sato","year":"2010","unstructured":"Sato H, et al. Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia\/lymphoma. Am J Pathol. 2010;176(1):402\u201315.","journal-title":"Am J Pathol"},{"key":"1906_CR89","doi-asserted-by":"publisher","first-page":"204","DOI":"10.12688\/f1000research.28146.2","volume":"10","author":"AJ Ogunleye","year":"2021","unstructured":"Ogunleye AJ, Romanova E, Medvedeva YA. Genome-wide regulation of CpG methylation by ecCEBPalpha in acute myeloid leukemia. F1000Res. 2021;10:204.","journal-title":"F1000Res"},{"issue":"6","key":"1906_CR90","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1007\/s10238-022-00980-4","volume":"23","author":"J Jian","year":"2023","unstructured":"Jian J, et al. DNA methylation-based subtypes of acute myeloid leukemia with distinct prognosis and clinical features. Clin Exp Med. 2023;23(6):2639\u201349.","journal-title":"Clin Exp Med"},{"issue":"1","key":"1906_CR91","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-019-0090-5","volume":"5","author":"H Jiang","year":"2020","unstructured":"Jiang H, et al. DNA methylation markers in the diagnosis and prognosis of common leukemias. Signal Transduct Target Ther. 2020;5(1):3.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"1906_CR92","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/s41556-018-0174-4","volume":"20","author":"J Liu","year":"2018","unstructured":"Liu J, et al. m(6)A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol. 2018;20(9):1074\u201383.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"1906_CR93","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41419-022-04661-8","volume":"13","author":"J Chen","year":"2022","unstructured":"Chen J, et al. Reducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors. Cell Death Dis. 2022;13(3):216.","journal-title":"Cell Death Dis"},{"issue":"3","key":"1906_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112279","volume":"42","author":"X Wang","year":"2023","unstructured":"Wang X, et al. The N(6)-methyladenine DNA demethylase ALKBH1 promotes gastric carcinogenesis by disrupting NRF1 binding capacity. Cell Rep. 2023;42(3): 112279.","journal-title":"Cell Rep"},{"issue":"10","key":"1906_CR95","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s13238-021-00866-3","volume":"12","author":"X Li","year":"2021","unstructured":"Li X, et al. The exploration of N6-deoxyadenosine methylation in mammalian genomes. Protein Cell. 2021;12(10):756\u201368.","journal-title":"Protein Cell"},{"issue":"11","key":"1906_CR96","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm.4416","volume":"23","author":"LP Vu","year":"2017","unstructured":"Vu LP, et al. The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23(11):1369\u201376.","journal-title":"Nat Med"},{"issue":"2","key":"1906_CR97","doi-asserted-by":"publisher","first-page":"191e9","DOI":"10.1016\/j.stem.2017.11.016","volume":"22","author":"H Weng","year":"2018","unstructured":"Weng H, et al. METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m(6)A modification. Cell Stem Cell. 2018;22(2):191e9-205e9.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"1906_CR98","doi-asserted-by":"publisher","first-page":"69e7","DOI":"10.1016\/j.stem.2022.12.003","volume":"30","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, et al. Decoding m(6)A RNA methylome identifies PRMT6-regulated lipid transport promoting AML stem cell maintenance. Cell Stem Cell. 2023;30(1):69e7-85e7.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"1906_CR99","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1182\/blood.2020009676","volume":"138","author":"M Feng","year":"2021","unstructured":"Feng M, et al. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner. Blood. 2021;138(1):71\u201385.","journal-title":"Blood"},{"issue":"4","key":"1906_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1628","volume":"14","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, et al. m(6)A-dependent upregulation of DDX21 by super-enhancer-driven IGF2BP2 and IGF2BP3 facilitates progression of acute myeloid leukaemia. Clin Transl Med. 2024;14(4): e1628.","journal-title":"Clin Transl Med"},{"issue":"2","key":"1906_CR101","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s12276-022-00735-x","volume":"54","author":"N Zhang","year":"2022","unstructured":"Zhang N, et al. The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability. Exp Mol Med. 2022;54(2):194\u2013205.","journal-title":"Exp Mol Med"},{"issue":"1","key":"1906_CR102","doi-asserted-by":"publisher","first-page":"81e8","DOI":"10.1016\/j.stem.2020.04.001","volume":"27","author":"J Wang","year":"2020","unstructured":"Wang J, et al. Leukemogenic chromatin alterations promote AML leukemia stem cells via a KDM4C-ALKBH5-AXL signaling axis. Cell Stem Cell. 2020;27(1):81e8-97e8.","journal-title":"Cell Stem Cell"},{"key":"1906_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2022.146353","volume":"822","author":"H Cui","year":"2022","unstructured":"Cui H, et al. DNA N6-Adenine methylation in HBV-related hepatocellular carcinoma. Gene. 2022;822: 146353.","journal-title":"Gene"},{"issue":"1","key":"1906_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-907X-4-1","volume":"4","author":"TT Dinh","year":"2013","unstructured":"Dinh TT, et al. Generation of a luciferase-based reporter for CHH and CG DNA methylation in Arabidopsis thaliana. Silence. 2013;4(1):1.","journal-title":"Silence"},{"issue":"1","key":"1906_CR105","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1038\/s41467-022-31627-3","volume":"13","author":"J Fang","year":"2022","unstructured":"Fang J, et al. Mechanistic basis for maintenance of CHG DNA methylation in plants. Nat Commun. 2022;13(1):3877.","journal-title":"Nat Commun"},{"issue":"1","key":"1906_CR106","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s44154-022-00052-3","volume":"2","author":"X Wu","year":"2022","unstructured":"Wu X, et al. Turnip mosaic virus manipulates DRM2 expression to regulate host CHH and CHG methylation for robust infection. Stress Biol. 2022;2(1):29.","journal-title":"Stress Biol"},{"issue":"7","key":"1906_CR107","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.3390\/ijms19072144","volume":"19","author":"A Bartels","year":"2018","unstructured":"Bartels A, et al. Dynamic DNA methylation in plant growth and development. Int J Mol Sci. 2018;19(7):2144.","journal-title":"Int J Mol Sci"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01906-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-025-01906-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01906-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T02:02:09Z","timestamp":1749261729000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-025-01906-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":107,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1906"],"URL":"https:\/\/doi.org\/10.1186\/s13148-025-01906-z","relation":{"references":[{"id-type":"doi","id":"10.1042\/BSR20190040","asserted-by":"subject"}]},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Shengjing Hospital of China Medical University. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}